Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ledipasvir + Vedroprevir + Tegobuvir + Ribavirin in HCV Genotype 1
NCT01353248Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- May 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ledipasvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started May 2011; status: completed.
02
Drugs
ledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01353248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01353248.